期刊文献+

饮食调整与乳腺癌的患病风险 被引量:2

Dietary Modification and Risk of Breast Cancer
下载PDF
导出
摘要 乳腺癌是全世界第二大恶性肿瘤。在美国和其他西方国家,乳腺癌是女性最常见的恶性肿瘤。西方国家乳腺癌的发病率大约是发展中国家的5倍。在美国和一些西方国家,由于采取了很多有效的措施来预防和治疗乳腺癌,因此乳腺癌的死亡率有所降低。这些措施包括:乳房X线照相筛查;对BRCA1和BRCA2基因突变高危家族人群进行监测;内分泌药物和化疗药物辅助治疗的合理应用;ERBB2 阳性(HER2)病人生物靶向治疗的应用。我们可以通过危险评估量表来预测女性未来几年或/和终生发生乳腺癌的危险性。对于有乳腺癌患病危险的女性而言,抗雌激素(他莫西芬和罗莱西芬)药物干预能使危险降低。然而,这些药物干预均有显著的副作用,没有大规模实施。芳香化酶抑制剂在高危人群中的应用目前也在研究之中。
出处 《美国医学会杂志(中文版)》 2007年第2期126-127,共2页 The Journal of the American Medical Association(Chinese Edition)
  • 相关文献

参考文献26

  • 1Boyle P. Breast cancer control: signs of progress, but more work required. Breast. 2005;14:429-438.
  • 2Kelsey JL, Horn-Ross PL, Breast cancer: magnitude of the problem and descriptive epidemiology, Epidemiol Rev, 1993;15:7-16
  • 3Berry DA, Cronin KA, Plevritis SK, et al. Effect of screening and adjuvant therapy on mortality from breast cancer. N Engl J Med. 2005;353:1784-1792.
  • 4Romond EH, Perez EA, Bryant J, et al. Trastuzumab plus adjuvant chemotherapy for operable HER2-positive breast cancer. N Engl J Med. 2005;353:1673- 1684.
  • 5Piccart-Gebhart M J, Procter M, Leyland-Jones B, et al. Trastuzumab after adjuvant chemotherapy in HER2-positive breast cancer. N Engl J Med. 2005;353:1659- 1672.
  • 6Hartmann LC, Degnim A, Schaid DJ. Prophylactic mastectomy for BRCA1/2 carriers: progress and more questions. J Clin Oncol. 2004;22:981-983.
  • 7Early Breast Cancer Trialists' Collaborative Group. Effects ot chemotherapy anti hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials. Lancet. 2005;365:1687-1717.
  • 8Gail MH, Brinton LA, Byar DP, et al. Projecting individualized probabilities of developing breast cancer for white females who are being examined annually. J Natl Cancer Inst, 1989;81:1879-1886.
  • 9Chlebowski RT, Col N, Winer EP, et al. American Society of Clinical Oncology technology assessment of pharmacologic interventions for breast cancer risk reduction including tamoxifen, raloxifene, and aromatase inhibition. J Clin Oncol. 2002;20:3328-3343.
  • 10Cuzick J, Powles T, Veronesi U, et al. Overview of the main outcomes in breast-cancer prevention trials. Lancet. 2003;361:296-300.

同被引文献21

引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部